Overall, a solid option for researchers looking for a high-quality compound from a reliable source
Healthon clinicians assess each patients medical history, treatment objectives, and regulatory constraints to determine whether a compounded option is medically necessary or if an FDA-approved medication is the better choice
Sugary foods and drinks: Candy, pastries, soda, and fruit juice cause rapid blood sugar fluctuations and add empty calories
Generation 2: Tirzepatide, dual-agonist GLP-1 + GIP Tirzepatide adds the glucose-dependent insulinotropic peptide (GIP) receptor to the GLP-1 target
Body measurements: Waist circumference, hip circumference, and if possible, a body composition measurement (using calipers, a smart scale, or DEXA scan)
Long-term results at 612 months can reach 2030%+ total body weight loss for some patients